Csis Health Ltd

CSIS Health Limited provides patient-centred clinical medication review solutions, primarily for older patients with multiple conditions and polypharmacy. The company states it is the only company licensed to apply AGS Beers Criteria and StoppStart Criteria, which are evidence-based prescribing guidelines used to identify potentially inappropriate medications. Its software reviews a patient's full medical record, including demographics, medications, conditions and lab results, to make prescribing recommendations and identify harmful or unnecessary drugs that can cause adverse drug events and avoidable hospital admissions. The company has an exclusive commercial partnership with the American Geriatrics Society (AGS) to deliver the first electronic version of the AGS Beers Criteria, and its technology is accredited as a Class 1 Medical Device, integrating with existing clinical systems across all healthcare settings.